<DOC>
	<DOC>NCT00403949</DOC>
	<brief_summary>The purpose of this study is to test the efficacy and safety of AzA 15% Gel in the treatment of mild to moderate perioral dermatitis.</brief_summary>
	<brief_title>A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Perioral</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<criteria>Clinical diagnosis of mild to moderate perioral dermatitis as diagnosed by the physician Investigator's Global Assessment (IGA) score at baseline of 2 or 3 (on scale from 0 to 4) 8 to 50 facial inflammatory lesions (papules, papulopustules, papulovesicles) History of atopic dermatitis of the face Granulomatous perioral dermatitis Facial acne, rosacea, facial demodicosis Seborrheic dermatitis of the nasolabial fold, Lupus erythematosus The use of topical or systemic medications that could affect the course of treatment and/or evaluation Severe diseases likely to interfere with the conduct / planned termination of the study (e.g. cancer, cardiac infarct, unstable angina pectoris, uncontrolled diabetes) Use of fluorinated toothpaste Planned exposure to artificial or intensive natural UV light of the test area throughout the course of the study Use / planned use of cosmetic products (e.g. creams, moisturizers, makeup, fatty lipstick) in the test area during the course of the study History of or suspected hypersensitivity to any ingredient of the study drugs Participation in another clinical study 4 weeks prior to and/or during the conduct of this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>